4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-052657
President and CEO sold 20,000 shares at $5.33 ($106,600)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-10-09 | Sale 10b5-1 | −20,000 | $5.33 | $106,600 | 5,295,796 | D |
| Open-market sales · 20,000 sh · avg $5.33 · $106,600 | |||||||
Loading xslF345X05/doc4.xml…